| Year | 2023 | 2022 |
|---|---|---|
| Total Revenue | 1.91B | 2.25B |
| Cost of Revenue | 1.07B | 1.08B |
| Gross Profit | 840.05M | 1.17B |
| Operating Expenses | 840.05M | 564.36M |
| Research and Development | 0 | 0 |
| Selling, General & Administrative Expenses | 39.11M | 49.49M |
| Selling & Marketing Expenses | 12.01M | 9.89M |
| General & Administrative Expenses | 27.1M | 39.61M |
| Other Expenses | 800.94M | 71.76M |
| Operating Income | 439.71M | 631.55M |
| Total Other Income/Expenses Net | 82.63M | 57.98M |
| Income Before Tax | 522.33M | 689.52M |
| Income Tax | 132.56M | 182.58M |
| Net Income | 389.78M | 506.94M |
| Basic EPS | 12.15 | 15.8 |
| EPS Diluted | 12.15 | 15.8 |
| Basic Average Shares | 32.08M | 32.09M |
| Diluted Average Shares | 32.09M | 32.09M |
| EBITDA | 545.44M | 706.41M |
Indo Borax & Chemicals Limited
INDOBORAX.NS
NSE
167.25INR-1.65 (-0.98%)
INDOBORAX.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 2.3B | 1.82B |
| Net Income | 389.78M | 506.94M |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -32.09M | -32.09M |
| Retained Earnings | 2.68B | 2.3B |
| Other Distributions | 351.49M | 446.89M |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 198.72M | 175.84M |
| Annual Depreciation | 22.85M | 15.56M |
| Capital Expenditure | -45.73M | -49.71M |
| Net PPE | 221.6M | 209.99M |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 0 | 0 |
| Goodwill (Previous Year) | 0 | 0 |
| Goodwill | 0 | 0 |